APEX Proximity Labeling Proteomics Service

APEX proximity labeling is a peroxidase-based method for identifying proteins located near a bait protein, subcellular compartment, membrane region, receptor neighborhood, or signaling microdomain. In a typical workflow, APEX or APEX2 is fused to a protein or targeted to a defined cellular region. After labeling activation, nearby proteins are biotinylated, enriched, digested, and analyzed by LC-MS/MS.

This approach is most helpful when location and timing matter. Some protein associations are weak, transient, membrane-associated, or difficult to preserve after cell lysis. APEX-based labeling marks nearby proteins in the cellular environment before enrichment, giving researchers a local snapshot that conventional pull-down approaches may miss.

APEX proximity labeling should still be interpreted with care. It identifies proximal proteins under the selected labeling condition; it does not automatically prove direct physical binding. We help you plan controls and analyze enrichment patterns so the dataset can support candidate discovery, mechanism exploration, and follow-up validation decisions.

What APEX Proximity Labeling Detects

APEX/APEX2 proteomics can support detection of:

• Proteins near a bait protein
• Proteins enriched around an organelle or membrane region
• Receptor-neighborhood proteins
• Signaling microdomain-associated proteins
• Local proteins that change after stimulation, mutation, or compound treatment
• Candidate interactors that may be difficult to recover by extraction-based methods

When APEX Is More Useful Than Conventional Pull-Downs

APEX proximity labeling may be a strong fit when your project involves:

• Fast local labeling windows
• Subcellular or organelle-centered questions
• Membrane, receptor, or signaling-complex neighborhoods
• Weak or transient associations
• Drug-treated vs control comparisons
• Local protein environments that may not survive Co-IP or AP-MS workflows

How to Interpret Proximity-Based Evidence

APEX-based results are best treated as proximity evidence. A strong candidate is usually supported by enrichment over control, replicate consistency, and a biological connection to the bait, compartment, or treatment condition. For direct-binding or functional conclusions, top candidates should be validated with orthogonal approaches.

We support APEX/APEX2 projects from feasibility review through LC-MS/MS data delivery and bioinformatics analysis. If you already have a labeling system, we can focus on enrichment, proteomics, and data interpretation. If the project is still being designed, we can review the bait, localization strategy, controls, and sample plan before the work begins.

1

Project Design and Control Planning

We begin with the scientific question: What protein, compartment, receptor, or cellular region are you trying to study? We then review your cell model, perturbation design, control groups, replicate plan, and expected data outputs.

QC focus: Can the design separate true local enrichment from general background labeling?

2

APEX Fusion, Localization, or Client Model Review

If your project uses a bait-APEX or compartment-targeted APEX fusion, localization matters. We review the fusion orientation, tag position, targeting sequence, expression strategy, and available localization evidence.

For client-prepared models, we also review how the cells were generated, labeled, collected, and stored.

QC focus: Does the APEX/APEX2 system localize to the intended region?

3

Labeling Condition and Cell-State Assessment

APEX/APEX2 labeling depends on controlled activation. Labeling conditions should fit the cell model and the biological question. For drug-response or stimulation studies, the timing of treatment and labeling should be designed carefully.

QC focus: Does the labeling condition support local protein capture without creating avoidable stress or confusing background?

4

Biotinylated Protein Enrichment

After labeling, cells are collected and lysed. Biotinylated proteins are captured using streptavidin-based enrichment. Wash conditions are selected to reduce nonspecific material while preserving the enriched labeled-protein pool.

QC focus: Is enrichment strong enough for LC-MS/MS, and are background signals controlled?

5

LC-MS/MS Acquisition

The enriched proteins are digested into peptides and analyzed by LC-MS/MS. The acquisition method is selected based on project scope, sample type, and comparison design.

QC focus: Are peptide recovery, MS signal quality, and sample consistency suitable for downstream analysis?

6

Candidate Ranking and Interpretation

We process the proteomics data to generate protein identification, quantification, enrichment results, and candidate ranking. If the study includes multiple conditions, we can compare proximity enrichment across groups.

QC focus: Are the final candidates supported by enrichment, controls, reproducibility, and biological context?

Common control options include:

CTA: Share Your Bait and Cell Model Details

APEX/APEX2 is not automatically the best fit for every protein-interaction question. The right approach depends on the biology, timing, compartment, sample model, and type of evidence needed.

APEX/APEX2 vs TurboID and BioID

APEX/APEX2 uses peroxidase-based labeling, while TurboID, miniTurbo, and BioID use biotin ligase-based labeling. These systems can answer overlapping questions, but they are not identical. APEX/APEX2 may be preferred when rapid local labeling is important, while TurboID or BioID may be better suited to other cell models, time windows, or labeling conditions.

APEX/APEX2 vs Co-IP-MS and AP-MS

Co-IP-MS and AP-MS are valuable when stable protein complexes can be recovered after lysis. APEX/APEX2 is more useful when the target environment is local, transient, membrane-associated, or difficult to preserve during purification.

APEX/APEX2 vs Spatial Proteomics and Organelle Fractionation

Spatial proteomics and organelle fractionation can help assign proteins to compartments, but they are not always bait-centered. APEX/APEX2 can provide a more local view around a bait, receptor, organelle region, or microdomain.

Selection Rules by Research Goal

Use APEX/APEX2 when:

• The question depends on rapid local labeling
• The target is an organelle, membrane region, receptor, or microdomain
• You need condition-dependent proximity comparison
• Conventional pull-downs may lose weak or transient associations

Consider another approach when:

• You need direct physical binding evidence
• You expect a stable protein complex that can be purified
• You need structural distance information
• You need broad localization profiling rather than local proximity

For orthogonal follow-up, related MS approaches may include chemical cross-linking mass spectrometry, Proteome-wide thermal stability profiling, or HDX-MS epitope mapping.

APEX/APEX2 projects are highly dependent on cell model, labeling strategy, and whether you submit cells, pellets, lysates, enriched material, or prepared peptides. The table below provides practical starting points for project planning based on general proteomics sample submission guidance.

What to Prepare Before Submission

Control, Replicate, and Treatment Information

Strong APEX proteomics starts with control design. If your project includes treatment or stimulation, please provide timing, concentration, treatment order, and matched control conditions. If you are not sure which controls fit your design, our team can review the study plan before sample preparation.

A useful APEX dataset should show more than “which proteins were detected.” We help you evaluate which proteins are enriched, how consistent the enrichment is, whether differences appear across conditions, and how the candidates fit known pathways or compartments.

This gives you a clearer short list for follow-up validation rather than an unfiltered protein table.

Source: An enzymatic cascade enables sensitive and specific proximity labeling proteomics in challenging biological systems

Background

APEX-based proximity labeling is valuable for subcellular proteomics because it can provide strong spatial and temporal control. However, conventional APEX2 activation can face background labeling and substrate-related concerns in some biological systems. This is especially important when the target compartment is small, difficult to isolate, or surrounded by proteins that can create nonspecific signal.

Sroka and colleagues addressed this challenge by developing iAPEX, an enzymatic cascade designed to locally generate hydrogen peroxide and improve specificity in APEX-based proximity labeling. The study tested this strategy across challenging biological contexts, including primary cilia proteomics.

Methods

The authors combined APEX2 with D-amino acid oxidase to activate labeling locally. In the primary cilia experiment, they applied the workflow in IMCD3 cells, enriched labeled proteins, digested proteins, labeled peptides with TMT, and analyzed samples using LC-MS-based quantitative proteomics.

The study compared iAPEX with conventional APEX2-based labeling under related experimental conditions. It also used downstream filtering and GO-based interpretation to evaluate specificity and enrichment quality.

Results

Figure 4 reports quantitative primary cilia proteomics using iAPEX compared with a conventional APEX2-based system in IMCD3 cells. The study quantified 5,982 proteins in this experiment. Under stringent enrichment filtering, iAPEX identified 175 high-confidence candidate cilia proteins, while the conventional APEX2-based system produced 799 putative cilia proteins under the same cutoff.

The authors showed that iAPEX separated known ciliary proteins from non-ciliary proteins more clearly than the conventional APEX2-based system. GO enrichment analysis also supported improved specificity for cilia-associated terms.

Conclusion

This case illustrates an important lesson for APEX proximity labeling projects: the labeling strategy, activation conditions, controls, and filtering logic strongly affect interpretability. For clients planning APEX/APEX2 proteomics, this supports the value of feasibility review, careful QC design, and bioinformatics filtering before drawing biological conclusions from candidate lists.

Figure 4 from Sroka et al. shows how APEX-based proximity labeling can be evaluated through quantitative proteomics, candidate filtering, and specificity-focused enrichment analysis.

This service is for Research Use Only and is not intended for clinical diagnosis, treatment selection, patient management, or medical decision-making.